| Joan Seoane Suarez; Judit Anido Folgueira; Patricia Anne GIBLIN; Peter Edward BAYLISS; Johan Fransson et al. (2021). Methods of quantifying lif and uses thereof. Patent Number: EP3806960A1. |
|
Patent |
|
| Joan Seoane Suarez; Judit ANIDO FOLGUEIRA; Peter Edward BAYLISS; Patricia Anne GIBLIN; Johan Fransson et al. (2021). Methods of quantifying lif and uses thereof. Patent Number: US20210190798A1. |
|
Patent |
|
| Joan Seoane Suarez; Judit Anido Folgueira; Robin Matthew HALLETT; Patricia Anne GIBLIN; Jeanne Magram et al. (2021). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: EP3806899A2. |
|
Patent |
|
| Joan Seoane Suarez; Judit Anido Folgueira; Robin Matthew HALLETT; Peter Edward BAYLISS; Ajitha JEGANATHAN et al. (2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: EP3807315A2. |
|
Patent |
|
| J·P·奥康奈尔; J·R·波特; A·劳森; B·克罗普里恩; S·E·拉佩奇 et al. (2021). Modulator assay. Patent Number: CN107810419B. |
|
Patent |
|
| J·赛瓦内苏阿雷斯; J·阿尼多福尔盖拉; P·A·吉布林; P·E·拜利斯; J·弗兰松 et al. (2021). Method for quantifying LIF and uses thereof. Patent Number: CN112654395A. |
|
Patent |
|
| Kodandaram Pillarisetti; Eric Thomas BALDWIN; Gordon D. Powers; Rosa Maria Fernandes CARDOSO; Ricardo Attar et al. (2021). ANTI-BCMA ANTIBODIES, BISPECIFIC ANTIGEN BINDING PARTICLES THAT BIND BCMA AND CD3, AND THEIR APPLICATIONS. Patent Number: PL3337824T3. |
|
Patent |
|
| S·J·塞奥内; F·J·阿尼多; R·M·哈勒; P·E·拜利斯; A·耶加纳桑 et al. (2021). Methods for improving response to anti-LIF antibody therapy in individuals with cancer. Patent Number: CN112703202A. |
|
Patent |
|
| Stephen G. Withers; Peter Rahfeld; Jayachandran Kizhakkedathu (2021). enzymatic compositions for carbohydrate antigen cleavage, methods, uses, apparatus and systems associated therewith. Patent Number: BR112021002899A2. |
|
Patent |
|
| Joan Seoane Suarez; Judit ANIDO FOLGUEIRA; Robin Matthew Hallett; Patricia Anne GIBLIN; Jeanne MAGRAM et al. (2021). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: US20210187106A1. |
CMCF-ID |
Patent |
Health |
| Mark Anderson; Debra Chao; Enrico L. Digiammarino; David A. Egan; Chung-Ming Hsieh et al. (2021). Prolactin receptor binding proteins and uses thereof. Patent Number: AU2021202954A1. |
CMCF |
Patent |
Health |
| Alexander, James (2021). Combined Geochemical, Mineralogical, and Structural Investigation of Auriferous Quartz Veins at the Vertigo Target, White Gold District, West-Central Yukon Territory, Canada. Supervisor: Banerjee, Neil R.; Van Loon, Lisa L.. ON, Canada: University of Western Ontario. https://ir.lib.uwo.ca/etd/8220. |
CLS-APS, CMCF-BM |
Masters Thesis |
Environment |
| Ngoc Ton (2021). Developing a Microbubble-based Contrast Agent for X-ray Phase Contrast Imaging to Detect Neovasculature in Breast Cancer. Supervisor: Machtaler, Steven; Wiebe, Sheldon. Saskatchewan, Canada: University of Saskatchewan. https://harvest.usask.ca/handle/10388/13397. |
BMIT-BM, BMIT-ID |
Masters Thesis |
Health |
| Nguyen, Jason (2021). Skeletal cell evolution: Comparing an amphibian model to earlier- and later-diverged vertebrates. Supervisor: Eames, Brian F. Saskatchewan, Canada: University of Saskatchewan. https://hdl.handle.net/10388/13327. |
BMIT |
Masters Thesis |
Health |
| Scire, Michelle Denise (2021). Structure and Function of MUC1 Specific Monoclonal Antibodies. Supervisor: Brooks, Cory L.. California, United States: California State University, Fresno. https://www.proquest.com/openview/5490f79cdbfb3740264d2fb8533321b1/. |
CMCF-ID |
Masters Thesis |
Health |